Ensign Peak Advisors, Inc Arcutis Biotherapeutics, Inc. Transaction History

Ensign Peak Advisors, Inc

  • $51.2 Billion
  • Q1 2025

A detailed history of Ensign Peak Advisors, Inc transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 1,988,389 shares of ARQT stock, worth $26.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,988,389
Previous 2,374,140 16.25%
Holding current value
$26.9 Million
Previous $33.1 Million 5.97%
% of portfolio
0.06%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$11.4 - $17.29 $4.4 Million - $6.67 Million
-385,751 Reduced 16.25%
1,988,389 $31.1 Million
Q4 2024

Feb 13, 2025
SELL
$8.31 - $14.99 $354,604 - $639,653
-42,672 Reduced 1.77%
2,374,140 $33.1 Million
Q3 2024

Nov 14, 2024
BUY
$8.32 - $11.0 $2.36 Million - $3.11 Million
283,110 Added 13.27%
2,416,812 $22.5 Million
Q2 2024

Aug 13, 2024
SELL
$7.24 - $12.53 $6.13 Million - $10.6 Million
-846,645 Reduced 28.41%
2,133,702 $19.8 Million
Q1 2024

May 14, 2024
BUY
$3.25 - $11.77 $3.09 Million - $11.2 Million
950,390 Added 46.82%
2,980,347 $29.5 Million
Q4 2023

Feb 14, 2024
BUY
$1.84 - $4.82 $2.22 Million - $5.8 Million
1,203,862 Added 145.73%
2,029,957 $6.56 Million
Q3 2023

Nov 13, 2023
SELL
$5.31 - $10.98 $34,222 - $70,766
-6,445 Reduced 0.77%
826,095 $4.39 Million
Q2 2023

Aug 14, 2023
BUY
$7.51 - $15.0 $2.6 Million - $5.19 Million
346,300 Added 71.22%
832,540 $7.93 Million
Q1 2023

May 15, 2023
BUY
$10.23 - $17.14 $17,268 - $28,932
1,688 Added 0.35%
486,240 $5.35 Million
Q4 2022

Feb 13, 2023
SELL
$13.96 - $20.4 $66,910 - $97,777
-4,793 Reduced 0.98%
484,552 $7.17 Million
Q3 2022

Nov 14, 2022
BUY
$17.85 - $26.95 $1.95 Million - $2.95 Million
109,450 Added 28.81%
489,345 $9.35 Million
Q2 2022

Aug 12, 2022
SELL
$16.33 - $22.2 $1.89 Million - $2.57 Million
-115,555 Reduced 23.32%
379,895 $8.1 Million
Q1 2022

May 16, 2022
BUY
$14.38 - $22.79 $1.09 Million - $1.73 Million
75,776 Added 18.06%
495,450 $9.54 Million
Q4 2021

Feb 11, 2022
BUY
$14.98 - $25.5 $445,445 - $758,268
29,736 Added 7.63%
419,674 $8.7 Million
Q3 2021

Nov 12, 2021
SELL
$19.28 - $27.1 $140,319 - $197,233
-7,278 Reduced 1.83%
389,938 $9.32 Million
Q2 2021

Aug 13, 2021
BUY
$24.42 - $34.75 $5.52 Million - $7.85 Million
226,013 Added 132.01%
397,216 $10.8 Million
Q1 2021

May 12, 2021
BUY
$24.47 - $36.98 $3.24 Million - $4.9 Million
132,599 Added 343.49%
171,203 $4.95 Million
Q4 2020

Feb 12, 2021
BUY
$17.82 - $31.73 $298,092 - $530,779
16,728 Added 76.47%
38,604 $1.09 Million
Q3 2020

Nov 12, 2020
BUY
$23.44 - $32.28 $336,973 - $464,057
14,376 Added 191.68%
21,876 $641,000
Q1 2020

May 11, 2020
BUY
$18.5 - $36.9 $138,750 - $276,750
7,500 New
7,500 $224,000

Others Institutions Holding ARQT

# of Institutions
252
Shares Held
126M
Call Options Held
605K
Put Options Held
170K
View Full List

About Arcutis Biotherapeutics, Inc.

ARQT Quotes by TradingView
  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $813M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email